InsiderTrades

Form 4/A for AMN AMN HEALTHCARE SERVICES INC

Accepted 2023-03-30 00:00:00 ET · period of report 2023-01-15 · accession 0001209191-23-021672 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2023-03-30 2023-01-15 AMN Jackson Denise L CLO M - OptEx $0.00 +1,172 14.2K +9% $0
DA 2023-03-30 2023-01-15 AMN Jackson Denise L CLO F - Tax $103.86 -344 13.8K -2% -$35.7K
DA 2023-03-30 2023-01-15 AMN Jackson Denise L CLO M - OptEx $0.00 -1,172 2,381 -33% $0
DA 2023-03-30 2023-01-15 AMN Jackson Denise L CLO A - Grant $0.00 +3,706 3,706 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-15 M A 1,172 $0.00 14,174 D — — (F2) This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction.
2 Common Common Stock 2023-01-15 F D 344 $103.86 13,830 D — — (F2) This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction.
3 Derivative Restricted Stock Units 2023-01-15 M D 1,172 $0.00 2,381 D — · — to — 1,172 Common Stock (F4) The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. (F5) The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. (F6) Restricted Stock Units do not have an expiration date
4 Derivative Restricted Stock Units 2023-01-15 A A 3,706 $0.00 3,706 D — · — to — 3,706 Common Stock (F4) The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. (F7) The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. (F6) Restricted Stock Units do not have an expiration date